KR20140042814A - 신규의 헥사하이드로사이클로펜타피롤론, 헥사하이드로피롤로피롤론, 옥타하이드로피롤로피리딘온 및 옥타하이드로피리딘온 화합물 - Google Patents

신규의 헥사하이드로사이클로펜타피롤론, 헥사하이드로피롤로피롤론, 옥타하이드로피롤로피리딘온 및 옥타하이드로피리딘온 화합물 Download PDF

Info

Publication number
KR20140042814A
KR20140042814A KR1020137033414A KR20137033414A KR20140042814A KR 20140042814 A KR20140042814 A KR 20140042814A KR 1020137033414 A KR1020137033414 A KR 1020137033414A KR 20137033414 A KR20137033414 A KR 20137033414A KR 20140042814 A KR20140042814 A KR 20140042814A
Authority
KR
South Korea
Prior art keywords
phenyl
trifluoromethoxy
pyrrolo
octahydro
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137033414A
Other languages
English (en)
Korean (ko)
Inventor
오렐리아 콩트
다니엘 훈지커
베르너 나이드하르트
마티아스 네테코벤
탄자 슐츠-가쉬
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20140042814A publication Critical patent/KR20140042814A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
KR1020137033414A 2011-05-17 2012-05-14 신규의 헥사하이드로사이클로펜타피롤론, 헥사하이드로피롤로피롤론, 옥타하이드로피롤로피리딘온 및 옥타하이드로피리딘온 화합물 Withdrawn KR20140042814A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11166437 2011-05-17
EP11166437.1 2011-05-17
PCT/EP2012/058852 WO2012156339A1 (en) 2011-05-17 2012-05-14 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds

Publications (1)

Publication Number Publication Date
KR20140042814A true KR20140042814A (ko) 2014-04-07

Family

ID=46124329

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137033414A Withdrawn KR20140042814A (ko) 2011-05-17 2012-05-14 신규의 헥사하이드로사이클로펜타피롤론, 헥사하이드로피롤로피롤론, 옥타하이드로피롤로피리딘온 및 옥타하이드로피리딘온 화합물

Country Status (11)

Country Link
US (1) US8501768B2 (cg-RX-API-DMAC7.html)
EP (1) EP2709984B1 (cg-RX-API-DMAC7.html)
JP (1) JP2014513703A (cg-RX-API-DMAC7.html)
KR (1) KR20140042814A (cg-RX-API-DMAC7.html)
CN (1) CN103562180B (cg-RX-API-DMAC7.html)
BR (1) BR112013028368A2 (cg-RX-API-DMAC7.html)
CA (1) CA2832334A1 (cg-RX-API-DMAC7.html)
ES (1) ES2537591T3 (cg-RX-API-DMAC7.html)
MX (1) MX346980B (cg-RX-API-DMAC7.html)
RU (1) RU2013153898A (cg-RX-API-DMAC7.html)
WO (1) WO2012156339A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497288B2 (en) * 2011-05-09 2013-07-30 Hoffmann-La Roche Inc. Hexahydropyrroloimidazolone compounds
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
JP2018507900A (ja) * 2015-03-13 2018-03-22 アッヴィ・インコーポレイテッド (インダゾール−4−イル)ヘキサヒドロピロロピロロン及び使用方法
CA3043184A1 (en) 2016-11-10 2018-05-17 Keros Therapeutics, Inc. Activin receptor type iia variants and methods of use thereof
IL320014A (en) 2018-01-12 2025-06-01 Keros Therapeutics Inc Activin receptor type iib variants and methods of use thereof
EP4121088A4 (en) 2020-03-20 2024-07-03 Keros Therapeutics, Inc. Methods of using activin receptor type iib variants
EP4121078A4 (en) 2020-03-20 2024-08-14 Keros Therapeutics, Inc. ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2001066531A1 (de) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one (und) ihre verwendung zur hemmung der hormonsensitiven lipase
CA2436943A1 (en) * 2000-12-01 2003-06-06 Cerep Sa Hydantoin compounds useful as anti-inflammatory agents
CN101115741A (zh) * 2005-02-15 2008-01-30 诺和诺德公司 3,4-二氢-1h-异喹啉-2-羧酸5-氨基吡啶-2-基酯
CN101336243A (zh) * 2005-12-05 2008-12-31 因塞特公司 内酰胺化合物和其使用方法
US7968585B2 (en) * 2006-04-25 2011-06-28 Eli Lilly And Company Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP2010524987A (ja) * 2007-04-27 2010-07-22 サノフィ−アベンティス 2−ヘテロアリール−ピロロ[3,4−c]ピロール誘導体及びscd阻害剤としてのそれらの使用
US20120010186A1 (en) 2009-03-23 2012-01-12 Merck Frosst Canada Ltd. Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
ME03452B (me) * 2009-10-23 2020-01-20 Janssen Pharmaceutica Nv Disupstituisani oktahi-dropirolo[3,4-c]piroli kao modulatori oreksin receptora
UY33227A (es) * 2010-02-19 2011-09-30 Novartis Ag Compuestos de pirrolopirimidina como inhibidores de la cdk4/6

Also Published As

Publication number Publication date
CN103562180A (zh) 2014-02-05
CA2832334A1 (en) 2012-11-22
HK1191942A1 (zh) 2014-08-08
BR112013028368A2 (pt) 2017-01-24
MX2013011628A (es) 2013-10-25
US20120295934A1 (en) 2012-11-22
JP2014513703A (ja) 2014-06-05
CN103562180B (zh) 2016-04-20
US8501768B2 (en) 2013-08-06
MX346980B (es) 2017-04-07
EP2709984B1 (en) 2015-03-18
WO2012156339A1 (en) 2012-11-22
EP2709984A1 (en) 2014-03-26
ES2537591T3 (es) 2015-06-09
RU2013153898A (ru) 2015-06-27

Similar Documents

Publication Publication Date Title
EP2709984B1 (en) New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
AU2025237942A1 (en) Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same
CN105189508B (zh) 作为janus激酶抑制剂的环烷基腈吡唑并吡啶酮
CN110023291B (zh) 三环rho激酶抑制剂
CA3125900A1 (en) 15-pgdh inhibitor
IL275058B2 (en) Sulfonylurea derivatives as modulators of the NLRP3 inflammasome
CA2839116C (en) Cyclic amine derivatives as ep4 receptor antagonists
AU2005262330B2 (en) Piperidine derivatives as NK1 antagonists
KR20120035160A (ko) Hsl 억제제로서의 아자환형 스파이로유도체
CN102317289A (zh) 作为β分泌酶抑制剂的内酰胺
TW202309051A (zh) 食慾素受體促效劑及其用途
EA036137B1 (ru) Производные тетрагидроизохинолина
CN119562944A (zh) α4β7整合素调节剂及其用途
WO2008100618A2 (en) Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
WO2008100620A2 (en) Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
KR20080063288A (ko) 신규 융합 피롤 유도체
WO2020095215A1 (en) Chemical compounds
JP2019529378A (ja) インドールカルボキサミド化合物の製造方法
KR20140011335A (ko) 아자스피로데카논 화합물
CN113754635A (zh) 稠环类化合物及其制备方法和用途
KR20140025411A (ko) Hsl 억제제로서의 신규 아자스피로데칸온 화합물
TW202108147A (zh) 化學化合物
JP6126080B2 (ja) 新規ヘキサヒドロピロロイミダゾロン化合物
WO2008100635A1 (en) 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
HK1191942B (en) New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20131216

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid